Printer Friendly

Browse Atrial fibrillation topic

Physiological aspects subtopic


1-17 out of 17 article(s)
Title Author Type Date Words
The Therapeutic Potential of MicroRNAs in Atrial Fibrillation. Xu, Xiaona; Zhao, Zhiqiang; Li, Guangping Mar 31, 2020 4868
Model-Based Quantification of Left Ventricular Diastolic Function in Critically Ill Patients with Atrial Fibrillation from Routine Data: A Feasibility Study. Kiefer, Nicholas; Oremek, Maximilian J.; Hoeft, Andreas; Zenker, Sven May 31, 2019 7764
Improved Multiscale Entropy Technique with Nearest-Neighbor Moving-Average Kernel for Nonlinear and Nonstationary Short-Time Biomedical Signal Analysis. Arunachalam, S.P.; Kapa, S.; Mulpuru, S.K.; Friedman, P.A.; Tolkacheva, E.G. Jan 1, 2018 6617
Beyond Natriuretic Peptides for Diagnosis and Management of Heart Failure. Ibrahim, Nasrien E.; Januzzi, James L., Jr. Report Jan 1, 2017 8797
Association of [CHADS.sub.2] and [CHA.sub.2][DS.sub.2]-VASc Scores with Left Atrial Thrombus with Nonvalvular Atrial Fibrillation: A Single Center Based Retrospective Study in a Cohort of 2695 Chinese Subjects. Huang, J.; Wu, S.L.; Xue, Y.M.; Fei, H.W.; Lin, Q.W.; Ren, S.Q.; Liao, H.T.; Zhan, X.Z.; Fang, X.H.; Report Jan 1, 2017 5277
Relationship between Angiotensin Converting Enzyme, Apelin, and New-Onset Atrial Fibrillation after Off-Pump Coronary Artery Bypass Grafting. Xu, Shu; Zhang, Jian; Xu, Yin-li; Wu, Hai-bo; Xue, Xiao-dong; Wang, Hui-shan Report Jan 1, 2017 5094
Total Adiponectin is inversely associated with platelet activation and [CHA.sub.2]D[S.sub.2]-VASc score in anticoagulated patients with Atrial fibrillation. Carnevale, Roberto; Pastori, Daniele; Peruzzi, Mariangela; De Falco, Elena; Chimenti, Isotta; Biondi Report Jan 1, 2014 3658
Integrative management of atrial fibrillation and natural blood thinning. Mikolai, Jeremy May 1, 2013 6223
Ask the doctors. Interview Aug 1, 2012 628
Treat thyroid disease to help protect your heart: thyroid disease can sometimes cause heart palpitations, but even worse it can increase your risk of atrial fibrillation. Apr 1, 2011 709
Evaluation of P wave and corrected QT dispersion in subarachnoid haemorrhage. Hanci, V.; Gul, S.; Dogan, S.M.; Turan, I.O.; Kalayci, M.; Acikgoz, B. Clinical report Jan 1, 2010 3470
Comparison of antithyroid drugs efficacy on P wave changes in patients with Graves' disease/Graves hastalarinda antitiroid ilaclarin P dalga degisiklikleri uzerine etkilerinin karsilastirilmasi. Berker, Dilek; Isik, Serhat; Canbay, Alper; Aydin, Yusuf; Tutuncu, Yasemin; Delibasi, Tuncay; Guler, Clinical report Aug 1, 2009 3887
Atrial fibrillation in hypertrophic cardiomyopathy: mechanisms, embolic risk and prognosis/ Hipertrofik kardiyomiyopatide atriyal fibrilasyon: Mekanizmalar, emboli riski ve prognoz. Nair, Ajith; Fischer, Avi Clinical report Dec 1, 2006 2608
Thyroid-related cardiovascular concerns limited to AFib. Johnson, Kate Apr 1, 2006 470
Studies identify risk factors for atrial fibrillation. Zoler, Mitchel L. Jan 1, 2005 606
Atrial fibrillation in women. (Clinical Capsules). Brief Article Dec 1, 2002 203
Atrial fib in elderly women tied to higher von Willebrand factor. (Same Result Not Seen in Men). Oct 15, 2002 220

Terms of use | Privacy policy | Copyright © 2020 Farlex, Inc. | Feedback | For webmasters